Clinical Trial Update: Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011) [Phase 1]

View source ↗

Summary

A Phase 1 trial update discusses the combination of bortezomib, cladribine, and rituximab (VCR) for Mantle Cell Lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Leustatin (cladribine)
• Rituxan (rituximab)
• Velcade (bortezomib)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Mantle Cell Lymphoma | Phase 1 | Status: UNKNOWN